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We report the isolation of a virus from a baboon imported from Kenya and the analysis of the nucleotide sequence of
the env gene. Comparison of the complete nucleotide sequence of the env gene of different HTLV-1 strains and the baboon
T-cell leukemia virus (designated BTLV) indicated similarities ranging from 92.5 to 97.4%. In contrast, only 89.1% similarity
was observed between the BTLV env sequence and that of simian T-cell leukemia virus (PtM3). The sequences corresponding
to the glycosylation sites, endoproteolytic processing site, and major immunological determinants were strictly conserved
between BTLV and HTLV-1. To characterize the expressed protein we used a vaccinia expression system, which indicated
that a protein of 62 kDa is encoded by the envelope gene. The protein acquired mostly high mannose modifications and
was localized predominantly in the endoplasmic reticulum. A fraction of the protein was expressed at the cell surface,
where it could induce membrane fusion of target cells. The existence of HTLV-1-like viruses in baboons indicates the
potential risk of transmission of such virus from these nonhuman primates to humans, thus highlighting the need for specific
screening for such viruses during xenotransplantation. q 1996 Academic Press, Inc.
INTRODUCTION Kenya. The nucleotide sequence of the envelope gene
and the properties of the protein encoded by the gene
Human T-cell leukemia virus type 1 (HTLV-1) is a C-
have been determined. The nucleotide sequences have
type retrovirus associated with adult T cell leukemia/
been compared with available sequences and the relat-
lymphoma (ATL) (Poiesz et al., 1980). ATL is character-
edness between different HTLV and STLV isolates and
ized by the malignant proliferation of CD4/ T lympho-
the possible evolutionary features are discussed.
cytes with symptoms including hypercalcemia, lymph-
oadenopathy, skin lesions, involvement of the liver or
MATERIALS AND METHODSspleen, and immunodeficiency (Stewart et al., 1994). In
addition, HTLV-1 infection is implicated in a demyelinat- Cells, viruses, and expression plasmid
ing disorder, tropical spastic paraparesis (Furukawa et
HeLa T4 cells (Maddon et al., 1986) and vaccinia virusal., 1992), and other conditions including alveolitis and
vTF7-3 (Fuerst et al., 1986) that synthesizes the T7 RNAarthritis. Simian T-cell leukemia virus type 1 (STLV-1)
polymerase in infected cells were obtained through theshares many properties with HTLV-1 and is associated
AIDS Research and Reference Reagent Program andwith the development of lymphomas in gorillas and ma-
used for the expression studies. The gene encoding thecaques, and leukemia in African green monkeys (Homma
envelope glycoprotein of baboon T-cell leukemia viruset al., 1984; Schatzl et al., 1992). HTLV-1 and STLV-1
(BTLV) was cloned under the control of the T7 promotershare common molecular features as well as pathogenic
in the expression vector pcDNA-1 Amp (Invitrogen). Anti-properties. The genomic organization of both viruses is
bodies used in this study were 1621 antiserum obtainedsimilar, consisting of LTR–gag–pol–env–tax/rex–LTR.
from the BTLV-infected baboon or a monoclonal antibodySequence analyses demonstrate that the genomes ex-
to HTLV-1 (0.5 Alpha supernatant) obtained through thehibit an overall similarity of 90–95% (Watanabe et al.,
AIDS Research and Reference Reagent Program (Mat-1986).
sushita et al., 1986).Although data are available on the nucleotide se-
quences of envelope genes from several HTLV and STLV
Cloning of the BTLV envelope gene from genomicisolates, not much information is available on the proper-
DNAties of the proteins from viruses isolated from nonhuman
primates. In this report, we describe the isolation of a Using primers (STLV-env1 5* CCGGATCCCAAAGAA-
novel virus from a baboon (Papio anubis) imported from AAAGACCACC 3* and STLV-env2 5* GGTTAACTATTG-
GCAGGGGAGGCTG 3*) which are conserved for both
HTLV-1 and STLV-1, PCR amplification was carried out1 To whom reprint requests should be addressed.
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using 2 units of Vent polymerase (New England Biolabs) left untreated. Both fractions were incubated at 377 for
15 hr and analyzed by SDS–PAGE. For tunicamycin treat-with 0.1 mg of the genomic DNA from a cell line devel-
oped from the infected baboon and each of the primers ment, transfected cells were treated with 5 mg/ml tuni-
camycin (Boehringer Mannheim) in DMEM for 30 minat 1 mM in a 100-ml volume containing 10 ml of 101 Vent
buffer and 200 mM each dNTP. The amplification was prior to and during labeling.
carried out for 20 cycles, denaturing at 957 (20 sec), an-
nealing at 557 (20 sec), extension at 727 (60 sec), and Indirect immunofluorescence
final incubation at 727 for 5 min. After precipitation and
Cells were seeded onto coverglasses and infection –removal of excess primers, the fragment was purified
transfection was performed as described above. At 6 hrand cloned into the eukaryotic expression vector pcDNA-
posttransfection, the expression and cellular localization1 Amp (Invitrogen).
of proteins were analyzed after fixing the transfected
cells for 10 min with paraformaldehyde (3.6%) and per-DNA sequencing
meabilizing for 5 min with 1.0% NP-40. Cells were then
Both strands of the envelope gene were sequenced treated with primary antibodies specific to the envelope
following the method recommended by United States protein followed by secondary mouse anti-human anti-
Biochemical, using Sequenase Version 2.0 T7 DNA poly- bodies conjugated with FITC. The coverslips containing
merase. Briefly, 5 mg of alkali-denatured DNA was used the cells were extensively washed with PBS, mounted on
for annealing with the primers at 657 for 2 min and the glass slides, and viewed in a fluorescence microscope.
mix was allowed to cool slowly to 357. To the annealed The nucleotide sequence reported in this paper has
template–primer complex (10 ml), 0.1 M DTT (1.0 ml), been submitted to GenBank under Accession No.
diluted labeling mix (2.0 ml), 5 mCi of [a-35S-dATP (0.5 ml) U56855.
and diluted Sequenase Version 2.0 (2.0 ml) were added
and incubated for 3 min at room temperature. Meanwhile, RESULTS
2.5-ml aliquots of termination mix (ddGTP, ddATP, ddTTP,
BTLV-infected baboon serum has strong reactivity toand ddCTP) were transferred to individual tubes and pre-
HTLV-1 proteinswarmed at 377 for 1 min. When labeling was complete,
aliquots of 3.5 ml each were transferred to tubes con-
As part of a collaborative project between the Yerkes
taining corresponding termination mixes and incubated
Regional Primate Research Center and the Institute of
further for 5 min at 377. The reaction was stopped and the
Primate Research in Nairobi, Kenya, feral and captive
samples were heated at 807, loaded onto an acrylamide –
nonhuman primates in Kenya were screened for antibody
urea gel, and visualized by autoradiography.
reactivity to HIV-1 and HIV-2. Several animal species
tested positive for antibodies to HIV-2 using a commer-Transfection, radioimmunoprecipitation, and protein
cially available ELISA kit (Genetic Systems HIV-2 EIA):analysis
Syke’s monkeys, red tail monkeys, African green mon-
keys, and baboons, including a captive baboon with aTransfection and protein analyses were done as de-
scribed previously (Vincent et al., 1993). Briefly, cells (5 code designation of 1621. Baboon 1621 was further eval-
uated following importation to the Yerkes Center.1 105) were seeded onto 35-mm dishes 1 day prior to
transfection. The cells were infected with vaccinia virus Baboon 1621 was confirmed to be seropositive to HIV-
2 (SIV) as well as HTLV-1 by Western blot (Fig. 1) andvTF7-3 (10 m.o.i.) which expresses the T7 RNA polymer-
ase, and DNA (5 mg) and Lipofectin (10 mg) mix were commercially available ELISA. The reactivity of the ba-
boon serum to HTLV proteins was evaluated by usingadded to the cells. At 15 hr posttransfection, the cells
were starved in medium lacking methionine/cysteine and HTLV-1-infected cell lysate as the antigen source and
then probing the blot strips with sera from an STLV-1-then labeled with 35S labeling mix containing methionine
and cysteine (Amersham) for 30 min. At the end of the positive sooty mangabey and from the baboon 1621. Sera
from the STLV-1-positive sooty mangabey reacted withlabeling period, label was removed and DMEM con-
taining excess cold methionine and cysteine was added the envelope (gp46) and with the products of gag polypro-
tein (CA, p24; MA, p19; and NC, p15) (Fig. 1, lane 2). Seraand chased for different times as indicated. Cell lysates
were prepared in RIPA buffer and proteins were immuno- from baboon 1621 exhibited a similar profile (lane 3). As
expected, sera from an uninfected sooty mangabey didprecipitated with specific antibodies. The immunoprecip-
itated proteins were extensively washed and analyzed not react with any of the HTLV-1 proteins. The proteins
were also compared by radioactive labeling and immuno-by SDS–PAGE and autoradiography. For experiments in-
volving Endo H treatment, the immunoprecipitated pro- precipitation to proteins from a cell line developed from
baboon 1621 (described below). The sera from baboonteins were divided into two equal (100-ml) aliquots. To
one aliquot 5 U Endo H (New England Biolabs) in sodium 1621 failed to precipitate any proteins of normal PBMC,
whereas proteins corresponding in mobility to thosephosphate buffer (pH 5.6) was added and the other was
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env gene was amplified using PCR primers as described
under Materials and Methods.
Nucleotide sequence of envelope gene of BTLV
The nucleotide sequence of the BTLV env gene and
the comparison with other HTLV-1 and STLV-1 isolates
is shown in Fig. 2. Of 1464 nucleotides, 1426 nt were
found to be identical between HTLV-1 (EL strain) (Paine
et al., 1991) and the BTLV isolate, i.e., 97.4% identity at the
nucleotide level. Comparison of the complete nucleotide
sequence of BTLV with different HTLV isolates revealed
that the baboon virus env gene showed striking similari-
ties ranging from 92.5 to 97.4%. In contrast, we found
only 89.1% identity (1305 nt identical of 1464 nt) between
the baboon virus env gene and that of STLV-1 (PtM3)
(Watanabe et al., 1985). When compared to the STLV-1
sequence, changes were clustered at the 5* end of the
gene and, to a lesser extent, dispersed throughout the
rest of the gene. Most base substitutions, however, were
at the second (7.5%) or third (74.0%) position.
FIG. 1. Immunoreactivity of serum from baboon 1621 to HTLV-1 pro- Because of the limitation in the availability of complete
teins. The Hut-102 cell line (HTLV-1 infected) was used as a source of sequence information for different STLV-1 isolates, we
antigen. Cells (2 1 107) were harvested from culture, washed, and compared a 522-nucleotide region which is available for
lysed in RIPA buffer (20 mM Tris–HCl, pH 7.5, 250 mM NaCl, 5 mM
most of the isolates and the corresponding segment fromEDTA, 0.5% sodium deoxycholate, and 1% NP-40). The lysate was
HTLV-1 isolates and BTLV. The results indicate thatcleared by centrifugation and run on a 12% polyacrylamide gel. Follow-
ing electroblot transfer to a PVDF membrane (Schleicher and Schuell) higher similarities ranging from 93.9 to 97.9% were ob-
strips were cut and used for immunodetection with serum samples and served between BTLV and HTLV-1 or STLV isolates from
a Rad-Free Detection kit (Schleicher and Schuell). The lanes represent Africa, Ivory Coast, and West Indies; the majority showed
results with serum samples from the following animals: (1) an STLV-
a similarity of more than 97.0%. The degree of similarity1-seronegative sooty mangabey monkey, (2) an STLV-1-seropositive
was less when the BTLV sequence was compared tosooty mangabey, (3) baboon 1621 infected with BTLV.
STLV-1 strains isolated from Asia (86.4 to 90.2%).
As observed for HTLV and STLV isolates, the BTLV
shown in the Western blot (Fig. 1) were precipitated from envelope protein was composed of 488 amino acids.
the cell line developed from baboon 1621 (not shown). Comparison of the amino acid sequence of the Env pro-
These results indicated the infection of the baboon 1621 tein of BTLV with that of HTLV-1 (strain MT2) (Gray et al.,
by a virus related to HTLV-1. 1990) revealed that 483 of 488 amino acids were identical
with an overall similarity of 99.0%. Furthermore, 2 of the
Development of a cell line and amplification of the
5 substitutions were conservative. The similarity of the
envelope-coding region from genomic DNA
BTLV Env protein with that of other HTLV-1 isolates
ranged from 95 to 98%. On the other hand, the aminoIn order to isolate a virus from baboon 1621, PHA/IL-
2-stimulated PBMC were cocultured with a number of acid similarity between the BTLV and the STLV-1 (PtM3)
Env proteins was only 93.6%, indicating a greater diver-cell types (normal baboon PBMC, CEMss, CEM1174,
Molt4 Clone 8, U937, and HuT78). All cocultures were gence. Of the 31 amino acid substitutions between the
BTLV and the STLV-1 Env proteins, most of the substitu-found to be negative for the presence of reverse tran-
scriptase (RT) activity except for the CEMss coculture, tions were clustered in the signal peptide and gp46, with
4 changes in gp21.which showed minimal amounts of RT activity in the su-
pernatant. This culture supernatant was tested for reac-
tivity in an HTLV-I and -II antigen capture assay. Using Expression of the BTLV envelope glycoprotein
limiting dilution, cell lines were cloned from this cocul-
ture. Twenty-eight separate colonies which grew in the In order to characterize the protein encoded by the
BTLV envelope gene, we performed transient transfec-0.1 cell/well dilution were expanded and tested for the
presence of HTLV-I and -II antigen. Three clones were tion and immunoprecipitation using the vaccinia T7 ex-
pression system. A monoclonal antibody for HTLV-1, hu-positive (4, 14, and 18), with the most strongly positive
culture being No. 4 (termed 1621 clone 4). Genomic DNA man antiserum to HTLV-1, and sera from baboon 1621
all specifically immunoprecipitated a glycoprotein withwas prepared from the 1621 clone 4 cell line and the
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lowed by SDS–PAGE. As shown in Fig. 3B, proteins syn-
thesized during the 30-min pulse and subsequently di-
gested with Endo H had a molecular weight of
approximately 44 kDa. Even after chases up to 5 hr, the
precursor protein did not exhibit forms which were resis-
tant to Endo H. This result indicates that the BTLV enve-
lope glycoprotein predominantly acquires high mannose
modifications, occurring in the endoplasmic reticulum.
In addition, we consistently found that the size of the
unglycosylated proteins made during tunicamycin treat-FIG. 3. Expression of the BTLV envelope glycoprotein. HeLa T4 cells
were infected with vTF7–3 vaccinia virus at m.o.i. of 10 and transfected ment was at least 2 kDa smaller than the deglycosylated
with plasmid DNA (3 mg) encoding the BTLV envelope protein. After proteins observed after Endo H digestion. With HTLV-1, a
15 hr cells were labeled for 30 min with 100 mCi of [35S]methionine similar molecular weight difference between tunicamycin
and cysteine labeling mix. (A) In one set, tunicamycin (5 mg) was added
and Endo H-treated proteins was observed (Paine et al.,(/) 30 min prior to the labeling and during labeling and other set was
1994). It is possible that the higher apparent molecularlabeled without tunicamycin (0). The cells were then washed, lysed,
and immunoprecipitated with 1621 antiserum and the proteins were weight of the Endo H-treated proteins could be due to
analyzed using 8% SDS–PAGE and autoradiography. a and b represent the residual N-acetyl glucosamine moieties remaining
the envelope precursor proteins which are glycosylated and unglyco- after Endo H digestion. The proteins were found to be
sylated, respectively. (B) Transfection and labeling were done as above.
relatively stable with a half-life of nearly 9 hr (data notAfter the 30-min pulse, the label was removed and medium containing
shown).unlabeled amino acids was added and incubated for up to 5 hr. The
immunoprecipitated proteins were divided into two equal portions. To The intracellular localization of the proteins was further
one portion 5 units of Endo H was added (/) and the other portion analyzed using indirect immunofluorescence staining. In per-
was left untreated (0). Both aliquots were incubated at 377 for 15 hr meabilized cells, the BTLV envelope was found in the perinu-
and analyzed by SDS–PAGE. a and b denote the glycosylated and
clear region as well as in a reticular staining pattern through-deglycosylated proteins, respectively.
out the cell (Fig. 4A). In addition, a low level of expression
was observed at the cell surface by staining of unpermeabil-
a molecular weight of approximately 62 kDa (data not ized cells (Fig. 4B). Control cells similarly processed were
shown). negative for envelope-specific staining both within the cell
The core molecular mass and nature of the modifica- (Fig. 4C) and on the cell surface (Fig. 4D).
tion on the protein were analyzed using tunicamycin
treatment of the transfected cells and endoglycosidase Induction of syncytia by the BTLV envelope protein
H treatment of the immunoprecipitated proteins. The
transfected cells were treated with tunicamycin for 30 HTLV induces syncytium formation upon infection of
susceptible cells. In an attempt to determine if BTLVmin prior to 35S labeling and analyzed by immunoprecipi-
tation (Fig. 3A). In the absence of tunicamycin, the enve- exhibited similar fusion properties, we analyzed the syn-
cytia-forming potential of the BTLV Env protein using alope precursor was found as a polyprotein of 62 kDa. A
series of bands of faster electrophoretic mobility was coculture method. When HeLa T4 cells expressing BTLV
Env were cocultured with XC cells, an RSV-transformedalso observed, which may represent incompletely glyco-
sylated forms of the protein. When glycosylation was rat cell line which is susceptible to cell fusion by HTLV-
1, generation of syncytia containing 15–20 nuclei wasinhibited, a protein band of approximately 46 kDa was
observed representing the unglycosylated form of the observed (Fig. 5A). The ability of the BTLV envelope pro-
tein to induce syncytia formation indicated that the pro-precursor glycoprotein. A small fraction of the glycosyl-
ated protein was also observed during the tunicamycin tein was proteolytically processed and appropriately ex-
pressed at the cell surface for subsequent interactiontreatment, possibly due to the limited time of exposure
to the drug prior to labeling. with its receptors. For comparison, we also cocultured
XC cells and the cell line developed from baboon 1621The nature of the modification of the protein was ana-
lyzed by labeling for 30 min and chasing in the presence from which BTLV was isolated. This coculture also re-
sulted in the induction of syncytia with XC cells (Fig. 5B),of unlabeled amino acids, and then digesting the immu-
noprecipitated proteins using endoglycosidase H fol- suggesting that expression of viral proteins is main-
FIG. 2. Comparison of env coding sequences of BTLV, HTLV-1, and STLV-1. Genomic DNA was prepared from the 1621 clone 4 cell line and
used as template for PCR amplification of the Env coding region. The env gene of BTLV was sequenced using Sequenase version 2 (United States
Biochemicals) and the nucleotide sequences were compared with the available sequences of HTLV strains (RH/K30, MT2, and EL) and STLV
isolates (PtM3 and PPA) using the GCG program. Note that only 522 nucleotides of STLV-1 from PPA were available for comparison (Koralnik et
al., 1994). The deduced amino acid sequence of BTLV is presented at the bottom (BTLV AA). The Accession Nos. used in the comparison are RH/
K30 (L03561), MT2 (M37747), EL (M67514), PtM3 (M11373), and PPA (U03160).
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FIG. 4. Localization of the BTLV envelope glycoprotein in transfected cells. HeLa T4 cells were transfected as described before. After 6 hr one
batch of cells was left unpermeabilized (B, surface) and other batch was permeabilized (A, internal) using 1.0% NP-40. Washed cells were incubated
with 1621 antiserum (1:500) and subsequently incubated with FITC-conjugated secondary antibodies. (C) (without primary ab) and (D) (vaccinia-
infected untransfected cells stained with both primary and secondary antibodies) are controls.
tained. Culture of vaccinia (vTF7-3)-infected HeLa T4 LTR suggested that there could be five different HTLV-1
genotypes from different geographic regions (Komuriancells alone (Fig. 5D) or in combination with XC cells (Fig.
5C) did not result in membrane fusion. These results et al., 1991; Ureta Vidal et al., 1994). Koralnik et al. (1994)
identified seven clades of STLV based on comparing 25indicated that the vaccinia-expressed envelope protein
possesses functional activity. STLV-1 sequences from 12 nonhuman primate species.
However, there are examples of STLV-1 sequences from
a single host species that fit into genetically distinctDISCUSSION
clades. We compared a segment between nucleotides
Previous studies have indicated that African STLV-1 867 and 1388 of BTLV env, which has been used in most
isolates exhibit a very close relationship among them- of the published comparisons among different isolates
selves and with HTLV-1 strain EL, isolated from an Afri- (Koralnik et al., 1994; Ibrahim et al., 1995), with the corre-
can ATL patient (Paine et al., 1991; Song et al., 1994). sponding nucleotides of different STLV-1 and HTLV-1
The sequence of the envelope gene obtained from BTLV strains using the GCG program. Among HTLV-1 isolates
is also similar to those of HTLV-1 EL. However, the amino the similarities ranged between 93.9 and 97.9%, the high-
acid sequence is more closely related to HTLV-1 strain est similarity being with H15 from Ivory Coast and lowest
MT2, which was isolated from Japanese ATL patients. similarity to HZ17 from Zaire. Compared to the partial
The HTLV strains EL and MT2 differ in 30 nucleotides env sequences of STLV clade S6 isolates from Africa,
and 3 amino acids. Paine et al. (1991) compared different the BTLV sequence exhibited similarities ranging from
HTLV-1 isolates and found fewer nucleotide and amino 94.6 to 96.1%. STLV-1 isolates from clade S7 (East Africa)
acid differences in gp41 between isolates obtained from also exhibited 96.0% similarity to BTLV. An isolate from
the same geographic region. STLV-1 strains from Africa a different species of baboon, PPA-5X28, showed the
exhibited a closer genetic relatedness among them- highest similarity (97.5%) to BTLV. In contrast, STLV-1
selves and tend to segregate with HTLV-1 strain EL from isolates from India or Indonesia (clade S1) were found to
equatorial Zaire. Sequence analyses of LTR, pol, and env show only 86.4 to 90.2% similarity to BTLV. A phylogenetic
analysis based on the comparison of the 522-nucleotideregions and restriction fragment length polymorphism of
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FIG. 5. Membrane fusion induced by the BTLV envelope protein. Cells (HeLa T4) were transfected as described under Materials and Methods.
At 6 hr posttransfection, the transfected cells were detached from the plates by versene treatment and pelleted by centrifugation. XC cells, similarly
processed, were mixed with HeLa T4 cells and the mixture of both cells was plated onto fresh dishes and cocultured for 15–20 hr. The cells were
then observed under the microscope for the presence of multinucleated cells. XC cells were also cocultured with 1621 clone 4 cells (a cell line
developed from BTLV infected baboon). (A) HeLa T4 cells expressing BTLV Env, cocultured with XC cells; (B) XC cells cocultured with 1621 clone
4 cells; (C) coculture of vaccinia-infected HeLa T4 and XC cells; and (D) HeLa T4 cells infected by vaccinia virus, vTF7-3.
segment of different HTLV-1 and STLV-1 isolates, using sites (McNearney et al., 1990). Endoproteolytic pro-
cessing has been shown to be an important determinantthe Kimura distance matrix (Kimura, 1980), showed that
the BTLV sequence clustered with several of the isolates for biological activity of many viral glycoproteins includ-
ing those of retroviruses. All retroviruses except visnafrom Kenya and Tanzania. However, the complete env
gene sequence of BTLV shows greatest similarity to that have a highly conserved cleavage site for a trypsin-like
protease (Arg-X-Lys/Arg-Arg) just prior to the beginningof HTLV-1 EL, which was isolated from Zaire. Since multi-
ple amino acid substitutions have been observed in the of the transmembrane subunit (McCune et al., 1986), and
this site is recognized by a cellular protease resulting inamino-terminal region of the envelope gene of STLV-1
(Song et al., 1994), comparison of such complete nucleo- the generation of the surface and transmembrane com-
ponents (Barr, 1991; Hallenberger et al., 1992). The BTLVtide and amino acid sequences will be required to deter-
mine the precise relationship of BTLV to other primate envelope glycoprotein (gp62) has the sequence Arg-Ser-
Arg-Arg at aa 308 to 312, which is the probable cleavageT-cell leukemia viruses.
site for processing of the precursor (gp62) into the extra-Several studies of retroviruses including HIV-1 indi-
cellular (gp46) and transmembrane (gp21) components.cated that sequence variation in the env gene may pro-
In our initial labeling and immunoprecipitation studies,foundly affect virus infectivity, cell tropism, and other bio-
no significant amount of gp46 was detected. However, inlogical properties (Li et al., 1987; Szurek et al., 1988;
subsequent labeling studies with [35S]cysteine, we haveFenyo et al., 1988). The envelope glycoproteins of all
detected gp46 within the cell and in the extracellularHTLV-1 and STLV-1 viruses contain five potential sites
medium (data not shown). Also, the observation of mem-(N-X-S/T) for N-linked glycosylation, which are conserved
brane fusion by BTLV Env supports the conclusion thatamong strains (Paine et al., 1991). The BTLV sequence
a fraction of the precursor was cleaved.also shows strict conservation of these glycosylation
sites. In this respect, HTLV-1 and STLV-1 differ from HIV- Since BTLV has the potential to be used for the devel-
opment of an animal model for HTLV-1, we compared its1 which exhibits variation among strains in glycosylation
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Barr, P. J. (1991). Mammalian subtilisins: The long-sought dibasic pro-sequence with the immunologically characterized re-
cessing endoproteases. Cell 66, 1–3.gions of HTLV-1. In gp46 of HTLV-1, epitopes involved in
Cianciolo, G., Kipnis, R., and Snyderman, R. (1984). Similarity betweengenerating neutralization and antibody-dependent cellu- p15E of murine and feline leukemia viruses and p21 of HTLV. Nature
lar cytotoxicity (Kuroki et al., 1992), B-cell activity (Baba 311, 515.
et al., 1993), and a major T-cell epitope (Baba et al., 1995) Fenyo, E. M., Morfeldt-Manson, L., Chiodi, F., Lind, B., von Gegerfelt,
A., Albert, J., Olausson, E., and Asjo, B. (1988). Distinct replicativehave been identified. All of these epitopes are maintained
and cytopathic characteristics of human immunodeficiency virus iso-in BTLV. Specific neutralization determinants were identi-
lates. J. Virol. 62, 4414–4419.fied between aa 88 and 98 which differed between HTLV-
Fuerst, T. R., Niles, E. G., Studier, F. W., and Moss, B. (1986). Eukaryotic
I and -II glycoproteins (Palker et al., 1992), and the BTLV transient-expression system based on recombinant vaccinia virus
sequences correspond to those of HTLV-1 and differ from that synthesizes bacteriophage T7 RNA polymerase. Proc. Natl. Acad.
Sci. USA 83, 8122–8126.HTLV-II. Based on sequence homology with the trans-
Furukawa, Y., Fujisawa, J., Osame, M., Toita, M., Sonada, S., Kubota,membrane proteins of feline and murine leukemia vi-
R., Ijchi, S., and Yoshida, M. (1992). Frequent clonal proliferation ofruses and HIV, a region (amino acids from 377 to 402)
human T cell leukemia virus type 1 (HTLV-1) infected T cells in HTLV-
in HTLV-1 gp21 was postulated to have immunosuppres- 1 associated myelopathy (HAM-TSP). Blood 80, 1012–1016.
sive properties (Cianciolo et al., 1984; Ruegg et al., 1989) Gray, G. S., White, M., Bartman, T., and Mann, D. (1990). Envelope gene
and this motif is also preserved in the BTLV Env protein. sequence of HTLV-1 isolate MT-2 and its comparison with other
HTLV-1 isolates. Virology 177, 391–395.Recently, HTLV-II has been shown to infect a wide
Hallenberger, S., Bosch, V., Angliker, H., Shaw, E., Klenk, H.-D., andvariety of cell types including cells of human, monkey, or
Garten, W. (1992). Inhibition of furin-mediated cleavage activation ofporcine origin (Li et al., 1996). Earlier studies employing
HIV-1 glycoprotein gp160. Nature 360, 358–361.
syncytium formation, vesicular stomatitis virus pseu- Homma, T., Kanki, P. J., King, N. W., Jr., Hunt, R. D., O’Connell, M. J.,
dotyping, and receptor interference (Sommerfelt and Letvin, N. L., Daniel, M. D., Desrosiers, R. C., Yang, C. S., and Essex,
M. (1984). Lymphoma in macaques: Association with virus of humanWeiss, 1990) indicated that HTLV-I and HTLV-II are likely
T lymphotrophic family. Science 225, 716–718.to employ the same cellular receptor which is encoded
Ibrahim, F., de The, G., and Gessain, A. (1995). Isolation and character-by human chromosome 17. BTLV is also likely to interact
ization of a new simian T-cell leukemia virus type 1 from naturally
with the same receptor because of its sequence relat- infected celebes macaques (Macaca tonkeana): Complete nucleo-
edness. Our results raise the possibility that under cer- tide sequence and phylogenetic relationship with the australo-mel-
tain circumstances, the opportunity may exist for the anesian human T-cell leukemia virus type 1. J. Virol. 69, 6980–6993.
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in an outbreak of STLV-1-related lymphoma in baboons variability of human T-cell leukemia virus type 1 depends more upon
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